A randomized controlled trial funded by the Crohn’s & Colitis Foundation demonstrated that an eight‑hour time‑restricted eating schedule markedly improved clinical outcomes for adults battling Crohn’s disease who were also overweight or obese. Over a 12‑week period, participants who limited food intake to an eight‑hour window experienced a 40 % drop in disease activity scores and a 50 % reduction in abdominal discomfort compared with those who ate normally.
Those following the fasting protocol lost roughly 5.5 lb, while the control group gained about 3.7 lb. Blood work revealed lower concentrations of leptin, plasminogen activator inhibitor‑1 (PAI‑1), and other inflammatory markers, indicating a calmer immune response despite no calorie‑restriction instructions.
The results were published in Gastroenterology. Physicians advise patients with inflammatory bowel disease to discuss any major dietary changes with their care team before adopting time‑restricted feeding.
How Time‑Restricted Feeding Works
Time‑restricted feeding (TRF) requires consuming all meals within a set eight‑hour window each day, followed by a 16‑hour fast. The study involved 35 adults with Crohn’s disease and excess weight; 20 were assigned to the TRF group and 15 continued their usual eating patterns. Researchers measured disease activity, systemic inflammation, and body composition at baseline and after the 12‑week intervention.
Support From the Crohn’s & Colitis Foundation
The project was backed by the Foundation’s Litwin IBD Pioneers program. Researchers highlighted that shifting when we eat—rather than what we eat—can boost metabolism, enhance immune function, and potentially sustain remission in Crohn’s patients.
"People with Crohn’s often seek practical, non‑pharmacologic tools to complement their medication," said the study’s lead investigator. "Our findings suggest that a biologically‑aligned eating window may offer a realistic, long‑term strategy for self‑managed wellness."
Reduced Visceral Fat and Gut Inflammation
Beyond symptom relief, the fasting group showed a notable decline in visceral fat and circulating inflammatory signals. Because both groups ate comparable foods in similar quantities, the benefits appear linked to meal timing rather than diet quality or calorie reduction.
While the data are promising, the investigators caution that larger, longer‑term trials are needed to confirm safety and durability of TRF for the broader IBD community.
This work was funded by the Crohn’s & Colitis Foundation (Litwin IBD Pioneers Grant ID: 879104) and the University of Calgary’s Imagine Network.